KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Change in Inventory: 2011-2022

Historic Change in Inventory for TherapeuticsMD (TXMD) over the last 12 years, with Sep 2022 value amounting to $551,000.

  • TherapeuticsMD's Change in Inventory rose 49.73% to $551,000 in Q3 2022 from the same period last year, while for Sep 2022 it was -$588,000, marking a year-over-year decrease of 2000.00%. This contributed to the annual value of $711,000 for FY2021, which is 78.69% down from last year.
  • According to the latest figures from Q3 2022, TherapeuticsMD's Change in Inventory is $551,000, which was up 119.56% from -$2.8 million recorded in Q2 2022.
  • In the past 5 years, TherapeuticsMD's Change in Inventory ranged from a high of $3.0 million in Q3 2019 and a low of -$2.8 million during Q2 2022.
  • In the last 3 years, TherapeuticsMD's Change in Inventory had a median value of $260,000 in 2021 and averaged $290,909.
  • As far as peak fluctuations go, TherapeuticsMD's Change in Inventory spiked by 1,145.66% in 2019, and later plummeted by 1,335.53% in 2022.
  • Over the past 5 years, TherapeuticsMD's Change in Inventory (Quarterly) stood at $889,449 in 2018, then soared by 49.29% to $1.3 million in 2019, then crashed by 136.07% to -$479,000 in 2020, then skyrocketed by 154.28% to $260,000 in 2021, then spiked by 49.73% to $551,000 in 2022.
  • Its Change in Inventory stands at $551,000 for Q3 2022, versus -$2.8 million for Q2 2022 and $1.4 million for Q1 2022.